Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

19 May 2022 10:27

RNS Number : 1108M
Mandarin Oriental International Ltd
19 May 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

19th May 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2022.

 

Trading conditions in the period improved in most parts of the world compared to the first quarter of 2021. Government restrictions on international and domestic travel, however, hampered the operating performance in Asia, with properties in China being particularly affected, and these challenges have continued into the second quarter.

 

In Europe, Middle East and Africa ('EMEA') and America, occupancy levels were lower than pre-pandemic levels for most properties, but room rates have held up well and are generally higher than in 2019. In Asia, both occupancy and room rates have remained substantially below pre-pandemic levels.

 

During the first quarter, the Group announced three new properties, in the Maldives, Costa Navarino and Cairo, increasing the Group's pipeline of new hotels and residences under development to 25.

 

The Group recorded an EBITDA loss of US$1 million in the first quarter. The impact of continued travel restrictions in much of Asia was offset by a more robust performance in EMEA and America and tightly-controlled corporate costs. Owned hotels and the management business recorded an underlying EBITDA loss of US$6 million and an underlying EBITDA profit of US$5 million, respectively.

 

Underlying losses (unaudited) for the Group were much improved compared to 2021, with the management business recording a marginal underlying profit (unaudited) in the period. As noted in the Group's 2021 full year results in March 2022, the outlook continues to improve in most markets, but there remains uncertainty in relation to China.

 

The Group's financial position is robust. Net debt at 31st March 2022 was US$542 million, and the Group held US$159 million of cash reserves and US$317 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley 

(852) 2895 9288

Matthew Bishop 

(852) 2895 9288

Brunswick Group Limited

Sunitha Chalam

(65) 6426 8188

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKKLBFLELLBBZ
Date   Source Headline
10th May 202311:44 amRNSDirector/PDMR Shareholding
4th May 20231:27 pmRNSAdditional Listing
4th May 20231:14 pmRNSResult of AGM
3rd May 202311:54 amRNSTransaction in Own Shares
28th Apr 202310:59 amRNSTotal Voting Rights
28th Apr 202310:50 amRNSJC&C Interim Management Statement
28th Apr 202310:23 amRNSPT Hero Supermarket Tbk Three Months 2023 Results
26th Apr 202311:30 amRNSTransaction in Own Shares
26th Apr 202310:36 amRNSDividend
24th Apr 202311:54 amRNSTransaction in Own Shares
21st Apr 202311:41 amRNSDirector/PDMR Shareholding
21st Apr 202311:10 amRNSDividend
20th Apr 202311:41 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSPT Astra 2023 First Quarter Financial Statements
18th Apr 202312:14 pmRNSTransaction in Own Shares
17th Apr 202310:26 amRNSDirectorate Change
3rd Apr 202311:24 amRNSTransaction in Own Shares
3rd Apr 202310:25 amRNSAnnual Financial Report
31st Mar 202311:15 amRNSTotal Voting Rights
30th Mar 202311:50 amRNSTransaction in Own Shares
29th Mar 202310:24 amRNSCirc re. Scrip Dividend Scheme
27th Mar 202310:34 amRNSBlock listing Interim Review
17th Mar 20239:28 amRNSPT Hero Supermarket Tbk Full Year 2022 Results
14th Mar 202310:33 amRNSTransaction in Own Shares
14th Mar 20239:26 amRNSDirector/PDMR Shareholding
2nd Mar 202312:38 pmRNSAudit Committee Membership Change
2nd Mar 202312:20 pmRNSJMH - 2022 Preliminary Results
2nd Mar 202311:20 amRNSHKLH - 2022 Preliminary Results
2nd Mar 20239:53 amRNSDairy Farm Intl - 2022 Preliminary Results
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
28th Feb 202310:10 amRNSJC&C - 2022 FY Results and Dividend
27th Feb 202312:17 pmRNSPT Astra – 2022 Full Year Financial Statements
31st Jan 202310:05 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20233:17 pmRNSDirector/PDMR Shareholding
13th Jan 202310:29 amRNSTransaction in Own Shares
30th Nov 202211:15 amRNSTotal Voting Rights
21st Nov 202210:55 amRNSTransaction in Own Shares
18th Nov 202211:15 amRNSTransaction in Own Shares
16th Nov 202211:27 amRNSTransaction in Own Shares
15th Nov 202210:37 amRNSTransaction in Own Shares
10th Nov 20229:47 amRNSInterim Management Statement
10th Nov 20229:42 amRNSInterim Management Statement
10th Nov 20229:40 amRNSInterim Management Statement
10th Nov 20229:37 amRNSInterim Management Statement
9th Nov 20229:34 amRNSJC&C Interim Management Statement
8th Nov 20229:31 amRNSCorrection: Director/PDMR Shareholding
7th Nov 202210:53 amRNSDirector/PDMR Shareholding
31st Oct 202210:39 amRNSTotal Voting Rights
31st Oct 202210:37 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.